Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niv Papo

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
FEBS Letters|February 24, 2018
Converting a broad matrix metalloproteinase family inhibitor into a specific inhibitor of MMP-9 and MMP-14Jason Shirian, Valeria Arkadash, Itay Cohen, et al.
The FEBS Journal|September 5, 2025
Modifying inhibitor specificity for homologous enzymes by machine learningDor S Gozlan, Reut Meiri, Gili Shapira, et al.
The Biochemical Journal|March 10, 2016
Combinatorial protein engineering of proteolytically resistant mesotrypsin inhibitors as candidates for cancer therapyItay Cohen, Olumide Kayode, Alexandra Hockla, et al.
Scientific Reports|February 14, 2019
PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinomaHonghai Ma, Alexandra Hockla, Christine Mehner, et al.
Journal of the American Chemical Society|October 5, 2021
Climbing Up and Down Binding Landscapes through Deep Mutational Scanning of Three Homologous Protein-Protein ComplexesMichael Heyne, Jason Shirian, Itay Cohen, et al.
International Journal of Biological Macromolecules|July 3, 2025
Structural analysis of nanobody interactions with their prostate-specific membrane antigen binding epitopesGal Alon-Zchut, Ran Zalk, Truc T Huynh, et al.
The Biochemical Journal|March 23, 2004
Effects of the antimicrobial peptide temporin L on cell morphology, membrane permeability and viability of Escherichia coliMaria Luisa Mangoni, Niv Papo, Donatella Barra, et al.
Cellular and Molecular Life Sciences : CMLS|August 27, 2020
The pro-apoptotic domain of BIM protein forms toxic amyloid fibrilsRavit Malishev, Shani Ben-Zichri, Ofek Oren, et al.
Bioengineering & Translational Medicine|May 19, 2017
Engineered ligand-based VEGFR antagonists with increased receptor binding affinity more effectively inhibit angiogenesisShiven Kapur, Adam P Silverman, Anne Z Ye, et al.
Scientific Reports|August 10, 2021
A KLK4 proteinase substrate capture approach to antagonize PAR1Eitan Rabinovitch, Koishiro Mihara, Amiram Sananes, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
FEBS Letters|February 24, 2018
Converting a broad matrix metalloproteinase family inhibitor into a specific inhibitor of MMP-9 and MMP-14Jason Shirian, Valeria Arkadash, Itay Cohen, et al.
The FEBS Journal|September 5, 2025
Modifying inhibitor specificity for homologous enzymes by machine learningDor S Gozlan, Reut Meiri, Gili Shapira, et al.
The Biochemical Journal|March 10, 2016
Combinatorial protein engineering of proteolytically resistant mesotrypsin inhibitors as candidates for cancer therapyItay Cohen, Olumide Kayode, Alexandra Hockla, et al.
Scientific Reports|February 14, 2019
PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinomaHonghai Ma, Alexandra Hockla, Christine Mehner, et al.
Journal of the American Chemical Society|October 5, 2021
Climbing Up and Down Binding Landscapes through Deep Mutational Scanning of Three Homologous Protein-Protein ComplexesMichael Heyne, Jason Shirian, Itay Cohen, et al.
International Journal of Biological Macromolecules|July 3, 2025
Structural analysis of nanobody interactions with their prostate-specific membrane antigen binding epitopesGal Alon-Zchut, Ran Zalk, Truc T Huynh, et al.
The Biochemical Journal|March 23, 2004
Effects of the antimicrobial peptide temporin L on cell morphology, membrane permeability and viability of Escherichia coliMaria Luisa Mangoni, Niv Papo, Donatella Barra, et al.
Cellular and Molecular Life Sciences : CMLS|August 27, 2020
The pro-apoptotic domain of BIM protein forms toxic amyloid fibrilsRavit Malishev, Shani Ben-Zichri, Ofek Oren, et al.
Bioengineering & Translational Medicine|May 19, 2017
Engineered ligand-based VEGFR antagonists with increased receptor binding affinity more effectively inhibit angiogenesisShiven Kapur, Adam P Silverman, Anne Z Ye, et al.
Scientific Reports|August 10, 2021
A KLK4 proteinase substrate capture approach to antagonize PAR1Eitan Rabinovitch, Koishiro Mihara, Amiram Sananes, et al.
Pageof 9